BRAF and melanoma: Since vemurafenib can inhibit the growth of BRAF mutant melanoma cells via apoptosis induction (34, 35), we explored whether apoptosis is involved in bilirubin-induced reversal effect of proliferation suppression triggered by vemurafenib.